Highlights Revium Rx.

Stocks

Market Closed - OTC Markets 13:09:54 2026-08-21 EDT			5-day change	1st Jan Change
1.430 ^USD	-14.37%		-.--%	+175.00%

08-13	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-22	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI

08-13	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-14	Revium Rx. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-31	Revium Rx. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01-16	Revium Rx. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-21	Revium Recovery Inc. Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections	CI
25-10-03	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-02-14	Revium Rx. has filed an IPO in the amount of $5 million.	CI
25-02-03	Revium Recovery Inc. completed the acquisition of LipoVac, Ltd.	CI
22-12-19	Revium Recovery Inc. entered into a letter of intent to acquire LipoVac, Ltd.	CI